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N6-methyladenosine (m6A) is the most abundant internal modification on mRNA which
influences most steps of mRNA metabolism and is involved in several biological functions.
The E3 ubiquitin ligase Hakai was previously found in complex with components of the m6A
methylation machinery in plants and mammalian cells but its precise function remained to be
investigated. Here we show that Hakai is a conserved component of the methyltransferase
complex in Drosophila and human cells. In Drosophila, its depletion results in reduced m6A
levels and altered m6A-dependent functions including sex determination. We show that its
ubiquitination domain is required for dimerization and interaction with other members of the
m6A machinery, while its catalytic activity is dispensable. Finally, we demonstrate that the
loss of Hakai destabilizes several subunits of the methyltransferase complex, resulting in
impaired m6A deposition. Our work adds functional and molecular insights into the
mechanism of the m6A mRNA writer complex.
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6-methyladenosine (m6A) is one of the most abundant
and well-studied mRNA modifications in eukaryotes1–4.
This modification plays a central role in almost every
aspect of mRNA metabolism, and is essential for several biological
processes such as cell differentiation1–8, DNA repair9, circadian
rhythm10–12, neurogenesis13 and sex determination14–16, among
others. Its dysregulation in human is associated with numerous
diseases, including metabolic alteration17, neuronal disorders18,19
and various types of cancers20–22. The downstream effects of m6A
are generally mediated by YTH domain RNA-binding proteins,
known as “m6A readers” that preferentially bind m6A modified
RNAs and affect their fate3.
m6A on mRNA is deposited co-transcriptionally by a con-
served multiprotein complex that can be divided into two stable
sub-complexes: the heterodimer METTL3/METTL14 also known
as m6A-METTL Complex (MAC) that contains the catalytic
activity, and the m6A-METTL Associated Complex (MACOM)
that is required for full MAC activity and includes WTAP (Fl(2)
d), VIRMA (Virilizer), RBM15/RMB15B (Spenito) and ZC3H13
(Flacc)23–25. More recently, another factor named HAKAI was
found associated with components of MACOM in plants and
human cells and required to maintain m6A level26,27.
The precise function of MAC and MACOM components has
been the subject of intense research over the past years. Structural
studies revealed that METTL3 and METTL14 form a stable
heterodimer28–30 and that METTL3 is the only factor that con-
tains the catalytic activity since METTL14 is unable to bind the
methyl group donor S-Adenosylmethionine. Nevertheless,
METTL14 is essential to support the interaction of the complex
with its RNA targets and to enhance METTL3 activity. WTAP
was shown to stabilize the interaction between METTL3 and
METTL14 and to recruit the METTL3/METTL14 heterodimer
into the nuclear speckles15,31. RBM15/RBM15B is an RNA-
binding protein that recognizes U-rich sequences on the mRNA
and is suggested to recruit the m6A machinery in close proximity
to these sites32. Furthermore, VIRMA was proposed to facilitate
selective m6A installation near the stop codon and in the 3′ UTR
of mRNAs through its interaction with polyadenylation cleavage
factors CPSF5 and CPSF627. Lastly, four recent studies identified
ZC3H13 as part of MACOM24,27,33,34. ZC3H13 was found to
stabilize the interaction between WTAP and RBM15 in mouse
embryonic stem cells as well as in flies and to contribute to the
localization of the writer complex to the nucleus. The only m6A
writer component whose function is still poorly explored
is HAKAI.
HAKAI, also known as CBLL1, is a RING-finger type E3
ubiquitin ligase that mediates ubiquitination and subsequent
endocytosis of the E-cadherin complex, leading to cell-cell
adhesion loss and increased cell motility35. HAKAI can also
regulate cell proliferation in an E-cadherin-independent manner
by affecting the ability of the PTB-associated splicing factor to
bind some of its RNA targets36. During the last decades, HAKAI
has been mostly studied in the context of epithelial-mesenchymal
transitions and cancer progression37. However, as aforemen-
tioned, it became increasingly clear that HAKAI is also a com-
ponent of the m6A biogenesis machinery in vertebrates as well as
in plants. HAKAI was identified as one of the strongest WTAP
interactors in mammalian cells38 and as part of an evolutionary
conserved protein complex including WTAP, VIRMA and
ZC3H1339. Furthermore, Hakai mutant in Arabidopsis thaliana
displayed mild developmental defects together with reduced m6A
levels26. Recently, we identified Hakai among the top enriched
proteins in our Spenito (Nito) interactome in Drosophila S2R+
cells, suggesting its evolutionary conserved role within the m6A
pathway24.
Here we report that Hakai is a conserved member of MACOM
and is essential for m6A deposition in flies. In line with its role in
the m6A pathway, Hakai functions in the sex determination
pathway and mediates splicing of Sex lethal. Moreover, its
depletion results in altered gene expression and splicing changes
that resemble the loss of other MACOM components. We find
that Hakai in flies encodes short and long protein isoforms that
display distinct subcellular localization. Its ubiquitin ligase
domain is required for homodimerization and interaction with
other MACOM components. Finally, we show that Hakai
removal leads to a severe reduction of Virilizer (Vir), Fl(2)d and
Flacc protein levels, indicating that Hakai is essential for main-
taining the stability of MACOM components.
Results
Drosophila Hakai is a conserved MACOM subunit. We pre-
viously found Hakai among highly enriched proteins in Nito and
RBM15 interactomes in Drosophila S2R+ and mouse ES cells,
respectively, suggesting it is a conserved member of MACOM
(Fig. 1a)24. In Drosophila, Hakai can generate four protein iso-
forms via alternative splicing: the two short and two long iso-
forms differ in the extension of the C-terminal region as a result
of intron retention and in the length of the second exon due to
alternative 3' splice sites in the first intron (Fig. 1b). All proteins
share a RING-type E3 ubiquitin ligase domain and an adjacent
C2H2-like zinc finger. This region is highly conserved and was
shown in mammals to be required for Hakai dimerization and
formation of the so-called “Hakai phosphotyrosine-binding
domain” (HYB domain) (Supplementary Fig. 1)40. Expression
of RNA isoforms was monitored during development by real-
time quantitative PCR (Supplementary Fig. 2). Both short and
long isoforms greatly overlapped with the m6A profile, showing
high enrichment during early embryogenesis and in ovaries,
which is consistent with the transcript distribution of the other
subunits of the m6A methyltransferase complex15,24. In addition,
the long isoforms were particularly elevated in males, suggestive
of a possible function during spermatogenesis. Intriguingly, when
we examined their subcellular localization in S2R+ cells we found
that the short isoform (302 aa) was present exclusively in the
cytoplasm with a strong signal at the cellular periphery, in con-
trast to the long isoform (473 aa) that was predominantly nuclear
(Fig. 1c). A similar result was obtained in BG3 cells, which are
cells derived from larval brains (Supplementary Fig. 3a). Fur-
thermore the long isoform colocalized to sites of transcription on
polytene chromosomes of salivary glands (Supplementary
Fig. 3b). Altogether, since m6A is deposited co-transcriptionally,
these results suggest that only the long isoform may be relevant
with regards to m6A biogenesis.
To address if Hakai indeed interacts with MACOM compo-
nents in Drosophila, we cloned Hakai cDNA encoding long (473
residues) isoform in a Myc-GFP-tagged expression vector and
transfected the construct in Drosophila S2R+ cells to carry out
Myc pull-down assay followed by mass spectrometry analysis. We
found that the tagged Hakai was able to immunoprecipitate all
MACOM components, even though the interaction with Nito was
just below the cutoff (Fig. 1d, Supplementary Data 1). Further-
more, Mettl3 and Mettl14 were absent from the precipitated
proteins, confirming our previous findings that the interaction
between MAC and MACOM is either weak or transient.
To confirm these results, we performed co-
immunoprecipitation assays in S2R+ cells. We found that Hakai
can interact with other MACOM components, irrespective of the
presence of RNA (Fig. 1e, f). Further confirmation of the
interaction between Hakai and Fl(2)d/Nito was obtained via
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Fig. 1 Hakai interacts with MACOM components. a Table indicating the names of MAC and MACOM components in Vertebrates and Drosophila. b
Schematic of the Hakai short and long protein isoforms depicting the RING domain (pink), the Zn-finger (grey) and the HYB domain (black). The green
domain indicates the alternative region of the second exon that is included in isoforms 311 aa and 473 aa. c Immunostaining of Myc-tagged Hakai short and
long protein isoforms overexpressed in S2R+ cells. GFP-tagged Barentsz protein served as a cytoplasmic marker. DAPI staining is shown in blue. The short
Hakai isoform localizes strictly to the cytoplasm, whereas the long isoform localizes to both cellular compartments with the enrichment in the nucleus.
Scale bars, 10 μm. d Identification of proteins interacting with GFP-Hakai-long in S2R+ cells based on label-free analysis of two replicate experiments
analyzed by quantitative MS-based proteomics. HAKAI immunoprecipitates alongside of all MACOM components. MACOM component proteins are
highlighted in red. A complete list of quantified proteins can be found in Supplementary Data 2. e, f Co-immunoprecipitation experiments were carried out
with lysates prepared from S2R+ cells transfected with Myc-tagged Hakai (long isoform) and HA-tagged Nito or Fl(2)d. In control lanes, S2R+ cells were
transfected with Myc alone and an identical HA-containing protein. Extracts were immunoprecipitated with anti-Myc antibody and immunoblotted using
anti-Myc and anti-HA antibodies. Two percent of input was loaded. The same experiment was repeated in the presence of RNase T1. Nito and Fl(2)d
interact with Hakai in an RNase-independent manner. Blots shown are representative of one biological replicate. g Yeast-two-hybrid assay to investigate
Hakai interaction with Nito and Fl(2)d. Proteins were cloned in yeast expression vectors and fused with either Gal4-DNA binding domain (BD) or Gal4-
DNA activation domain (AD). Indicated combinations of vectors were co-expressed in yeast and empty vectors encoding only activation or binding domain
were used as control (Ctr). Recovered colonies were spotted on plates lacking Leucine and Tryptophan (-Leu, -Trp) as well as selection plates lacking
amino acids Leucine, Tryptophan and Histidine (-Leu, -Trp, -His). AD-Hakai long isoform interacts with BD-Fl(2)d and BD-Nito. Source data for Western
blots and the yeast-two-hybrid assay are provided as a Source Data file.
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yeast-two-hybrid (Y2H) assay (Fig. 1g). However, interaction
between Hakai and Flacc was not detected in this assay and Vir
could not be successfully expressed in yeast, probably due to its
large size. Furthermore, in agreement with the human HAKAI
structure40, we observed that the Hakai fly orthologue could
homodimerise, as well as Fl(2)d and Nito, which was not reported
previously (Supplementary Fig. 4a, b).
Altogether our data indicate that Hakai is a component of the
m6A machinery in flies, that it interacts with MACOM
components, and that several subunits within this complex likely
exist in more than one copy.
Vir functions as a scaffold for MACOM component interac-
tion. To gain better mechanistic insights of Hakai within
MACOM, we precisely mapped the intermolecular interactions
between the different components of the complex. To do so, we
performed co-immunoprecipitation experiments in the presence
of RNase A using full length as well as fragments of MACOM
subunits in different combinations (Fig. 2a). Results from these
experiments revealed that Hakai N-terminal region (residues 1-
295, common to both isoforms) interacts with the N-terminal
region of Vir (residues 1–130) (Fig. 2b, c), while the middle
region and C-terminus of Fl(2)d (residues 125-536) binds Vir C-
terminal (residues 1501–1854) (Fig. 2d, e). The same region of Fl
(2)d was also required for homodimerisation (Supplementary
Fig. 4a). These data suggest that Vir may mediate the interaction
between Fl(2)d and Hakai. To address this possibility, we tested
whether Hakai and Fl(2)d still interact in the absence of Vir. The
co-immunoprecipitation assay revealed that the interaction was
strongly compromised upon vir KD (Fig. 2f and Supplementary
Fig. 5a). Similarly, the interaction between Hakai and Nito was
dramatically reduced (Supplementary Fig. 5a, b). In contrast, the
lack of Hakai did not interfere with the association of Fl(2)d with
Nito or Vir (Supplementary Fig. 5c–e). Therefore these results
suggest that Vir likely stabilize the interaction between Fl(2)d,
Hakai and Nito (Fig. 2g).
We next explored whether these interactions are conserved in
the human MACOM. To this end, we overexpressed several
human MACOM subunits (Supplementary Fig. 6a) in HEK293T-
cells and performed co-imunoprecipitation experiments in the
presence of RNase A. We found that the interaction between
HAKAI and the N-terminal domain of VIRMA (residues 1–130)
is conserved between Drosophila (Fig. 2b, c) and humans
(Supplementary Fig. 6b, c). We further showed that a region of
HAKAI spanning residues 87–105, which is not present in the
previously determined structure40, is critical for this interaction
(Supplementary Fig. 6c, lanes 11–12). Similarly, the predicted
structured region of the Fl(2)d homologue WTAP (residues
1–249) co-imunoprecipitated with VIRMA (Supplementary
Fig. 6d). In case of human VIRMA, we identified two distinct
interaction domains. On one hand VIRMA interacts with WTAP
through its C-terminal domain (residues 1575–1812) (Supple-
mentary Fig. 6e), as shown for Drosophila. We also identified a
second WTAP interacting site in the central region of the protein
spanning residues 335-1130 (Supplementary Fig. 6e, lane 14).
Interestingly, truncating this region further from either side
abolished the interaction (Supplementary Fig. 6e, lanes 15–16),
suggesting that WTAP binding involves multiple interaction sites
or that the truncations disrupt the VIRMA protein fold.
Altogether, these results demonstrate that VIRMA serves as an
interaction platform for the assembly of HAKAI and WTAP into
the MACOM complex in both Drosophila and humans (Fig. 2g, h).
Hakai is required for mRNA m6A methylation and alternative
splicing of Sex lethal (Sxl). A key role for m6A in Drosophila has
been shown in alternative splicing of Sex lethal (Sxl), where it is
required for autoregulation in females41. In females, Sxl binds to
either side of an alternative exon containing a stop codon and
blocks the splice sites to skip this exon, which is only included in
males. In addition, Sxl also prevents expression of the dosage
compensation factor msl-2, which is expressed only in males to
upregulate transcription from the single X chromosome twofold.
Loss of m6A interferes with sexual differentiation in females and
increases female lethality due to aberrant dosage
compensation14–16. Hence, we wondered whether loss of Hakai is
also required for mRNA m6A methylation and interferes with
Drosophila sex determination and dosage compensation.
We obtained a previously characterized imprecise transposon
excision line in the Hakai gene42. This Hakai1 allele lacks the
coding region covering the N-terminus and the RING-finger
domain, and is considered to be a null loss of function (Fig. 3a).
In addition, we used the CRISPR/Cas9 approach to generate
Hakai, which encodes an early truncated product (first 57aa).
When we crossed Hakai1 to either of the two deficiency alleles (Df
(2L)Exel8041 or Df(2L)Exel6044) to normalize genetic back-
ground effects, we found that the mutants died in the pupal stage
(n= 240). The m6A level of Hakai1/Df(2L)Exel8041 pupae was
reduced compared to the control (Fig. 3b–d), but not completely
absent as in Mettl3null mutants14.
To test whether Hakai is required for Sxl autoregulation, we
made use of a genetically sensitized background based on reduced
Sxl levels by removal of one copy of daughterless (da), which is
involved in Sxl transcription, and one copy of Sxl required for Sxl
autoregulation. In the progeny of a cross between daDf/+;
Mettl3null/+ females and Sxl7B0 null males, most females died
(Fig. 3e). Likewise, also removal of one copy of Hakai killed
females (Fig. 3e).
Furthermore, when we crossed Hakai/CyO females, which
harbours an early stop codon, to Df(2L)Exel8041/CyO males to
normalize genetic background, we observed strong female
lethality compared to CyO balancer-carrying control animals
(149 females and 144 males, Fig. 3f). Although the two females we
obtained did not show sexual transformation, all male flies were
flightless (n= 44), as observed for Mettl3null and Mettl14null
mutants14–16.
To further confirm the involvement of Hakai in Sxl alternative
splicing we made use of the female-lethal vir2F allele14. We found
that removal of one copy of Hakai restored female viability of
vir2F/Df(2R)BSC778 females by correcting Sxl alternative splicing
(Fig. 3g), as shown previously for other components of the
methyltransferase complex14,24.
Lastly, to demonstrate a role for Hakai in the sexual
differentiation of Drosophila females we made use of the vir2F/
virts genetically sensitized background, which occasionally shows
patches of darkly pigmented male tissue in abdominal segments 5
and 6 in these females (Fig. 3j–l). Strikingly, removal of one copy
of Hakai led to male pigmentation in the vast majority of these
females (Fig. 3h, m) and a switch of Sxl alternative splicing to the
male mode, including the otherwise skipped male exon (Fig. 3i,
lane 5). Some females also displayed intersexual development of
genitals (Fig. 3n). Intriguingly, loss of Hakai in the vir2F/virts
genetically sensitized background revealed tissue-specificity in Sxl
regulation as alternative splicing in the front part of females (head
and thorax) was not altered, and also these females did not
display male sex combs (Fig. 3h), suggesting the m6A pathways
main function could be to guarantee robust Sxl alternative
splicing across different tissues.
Hakai regulates the m6A pathway in Drosophila. To further
corroborate Hakai as a genuine m6A writer in Drosophila, we
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depleted its product in S2R+ cells and compared its effect with
the KD of other m6A pathway components. In agreement with
Hakai being part of the m6A writer complex, its loss led to a
significant reduction of m6A levels on mRNA as measured by
mass spectrometry (Fig. 4a). However, this reduction (32%) was
not as pronounced as the m6A reduction observed upon deple-
tion of the Mettl3/Mettl14 heterodimer (59%), which is consistent
with the results obtained by TLC from Hakai1/Df mutant pupae
(Fig. 3c, d). We next investigated its involvement in the regulation
of m6A-dependent splicing events. We previously reported
changes in the splicing pattern of several transcripts upon KD of
individual m6A writers15,24. Splicing isoform quantification by
RT-qPCR of two of the affected transcripts, fl(2)d and Hairless,
resulted in a comparable isoform shift in Hakai KD and Mettl3/
Mettl14 KD in S2R+ cells (Fig. 4b). On a transcriptome-wide
level, depletion of Hakai resulted in changes in gene expression
and splicing that substantially overlap with changes occurring
upon KD of other components of the m6A machinery (Fig. 4c;
Supplementary Fig. 7). In particular, Hakai KD led to an increase
of both alternative 5′ splice site usage and intron retention,
Fig. 2 Virilizer acts as a scaffold between Hakai and Fl(2)d. a Schematic representation of proteins and protein fragments used for Drosophila co-
immunoprecipitation assays. b–e Co-immunoprecipitation experiments were carried out with lysates prepared from S2R+ cells transfected with Myc-GFP-
tagged Virilizer (full length or fragments) and HA-tagged Hakai-long (b), Myc-GFP-tagged Hakai-long (full length or fragments) and HA-tagged Virilizer
(c), Myc-GFP-tagged Virilizer (full length or fragments) and HA-tagged Fl(2)d (d), Myc-GFP-tagged Fl(2)d (full length or fragments) and HA-tagged
Virilizer (e). In control lanes, S2R+ cells were transfected with Myc-GFP alone and an identical HA-containing protein. Extracts were incubated with
magnetic agarose GFP binder beads and immunoblotted using anti-Myc and anti-HA antibodies (b–e), as indicated. Two percent of input was loaded. The
experiment was performed in the presence of RNase A. Images shown are representative of two biological replicates. f Co-immunoprecipitation
experiments were carried out with lysates prepared from S2R+ cells transfected with Myc-GFP-tagged Hakai-long and HA-tagged Fl(2)d upon control
(LacZ) or vir KDs. In control lanes, S2R+ cells were transfected with Myc-GFP alone and an identical HA-containing protein. Extracts were incubated with
magnetic agarose GFP binder beads and immunoblotted using anti-GFP and anti-HA antibodies. Two percent of input was loaded. g, h Schematic
representing the interaction domains between Hakai, Vir and Fl(2)d derived from co-IP experiments in Drosophila (g) or HEK393T cells (h). Orange dotted
lines indicate the second interaction domain between Human WTAP and VIRMA. Source data for western blots are provided as a Source Data file.
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consistent with our previous findings on the individual MACOM
component depletion (Fig. 4d24). Note that depletion of MACOM
components has a stronger impact on gene expression and spli-
cing compared to the loss of MAC components. This is consistent
with previous genetic data showing that Mettl3 and Mettl14 are
dispensable for fly viability while MACOM subunits are not14–16,
supporting additional function(s) for MACOM components.
Altogether, these results demonstrate that Hakai is a bona fide
component of MACOM and is required for m6A biogenesis and
function.
Fig. 3 Hakai is required for m6A methylation and sex determination by regulating Sex-lethal alternative splicing. a Schematic of the Hakai genomic
locus depicting the transposon (black triangle) used to generate the deletion in the Hakai1 allele and the premature stop codon present in the Hakai allele,
and the epitope-tagged UAS constructs of the short and long isoforms. Schematic diagram of a 2D thin-layer chromatography (TLC) depicting standard
and methylated nucleotides (b), and TLCs depicting m6A in control (c) and Hakai1/Df(2L)Exel8041 pupae (d). e Viability of female flies from a cross of the
indicated genotypes mated with Sxl7BO males. The loss of one copy of Mettl3 or Hakai significantly reduces female survival in a genetic background where
one copy of Sxl and da are absent. Viability was calculated from the numbers of females compared with males, and statistical significance was determined
by a χ2 test (Graphpad Prism). ∗∗∗P≤ 0.0001). Unpaired two-tailed Student’s t-test for unequal variances. f Viability of Hakai/Df(2L)Exel8041 flies. g The
viability of female flies with homozygous vir2F mutation can be rescued by the loss of a single copy of Hakai. Viability was calculated from the numbers of
homozygous vir2F females compared with heterozygous balancer-carrying siblings, and statistical significance was determined by a χ2 test (Graphpad
Prism). ∗∗∗P≤ 0.0001). h–n External sexual differentiation (h, j–n) and Sxl alternative splicing in abdomen and head/thorax fraction (i) of control, vir2F/virts
and Hakai1 vir2F/virts female flies. The gel shown in (i) is a representative of two biological replicates. The marker is a 100 bp DNA ladder with 500 bp
indicated on top. Note that Sxl alternative splicing in Hakai1 vir2F/virts female abdomens is switched to the male mode and that these females display male
pigmentation (h, m), but no male sex combs (h). Source data for TLC, fly numbers and RT-PCR gels are provided as a Source Data file.
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Fig. 4 Hakai regulates m6A levels and m6A-dependent splicing events. a LC–MS/MS quantification of m6A levels in either control samples or mRNA
extracts depleted for the indicated proteins in S2R+ cells. The bar chart shows the mean with standard error (SE) of three biological replicates and three
technical measurements. KD of Hakai results in substantial reduction of m6A levels. ∗∗∗P= 7.49E−04 (Hakai KD), ∗∗∗∗P= 7.51E−06 (Mettl3, Mettl14 KD).
Unpaired two-tailed Student’s t-test for unequal variances. b Relative isoform quantification of m6A-regulated genes (fl(2)d and Hairless) upon depletion of
the indicated components. The bar chart shows the mean with standard error (SE) of three biological replicates and three technical measurements. Hakai is
required for m6A-dependent splicing regulation. c Number of differentially spliced events upon knockdown of the indicated proteins (left) and common
differentially spliced targets (right) (FDR < 0.1). d Radar charts display relative distribution of differentially spliced events upon knockdown of Fl(2)d and
Hakai. Alternative 5’splice site (A5SS) selection and intron retention (RI) are overrepresented events upon loss of m6A writer components. Source data for
m6A measurement, qPCR and RNA-seq are provided as a Source Data file.
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The Hakai ubiquitination domain but not its activity is
required for maintaining MACOM integrity. We next sought to
address the molecular role of Hakai within MACOM. As Hakai is
a well-studied E3 ubiquitin ligase in mammals, we wondered
whether its ubiquitination activity plays any role within the m6A
pathway. To address this possibility, we generated constructs
expressing either the wild-type Hakai cDNA (HakaiWT) or a
cDNA containing point mutations in the RING domain
(HakaiΔRING) that should abolish ubiquitination activity (see
“Methods”). We then performed rescue experiments in our Hakai
mutant flies and found that while the wild-type form was able to
rescue the lethality, the mutated version failed to do so. This
indicates that the RING domain is required for fly viability.
We therefore wondered if Hakai might regulate m6A levels by
ubiquitination of MACOM components. To investigate this
possibility we examined our previous ubiquitylome datasets from
Drosophila S2 cells and found that Fl(2)d and Nito were among
the ubiquitinated proteins43. Thus, we cloned both proteins in a
GFP-tag containing vector and expressed them in control and
Hakai depleted S2R+ cells to monitor their ubiquitination. We
immunoprecipitated both proteins under stringent 8 M Urea
conditions and while we could not detect any ubiquitination
signal for Nito, Fl(2)d appeared to be polyubiquitinated, as shown
by a strong shift in molecular weight by more than 100 kDa
(Supplementary Fig. 8a). Using mass spectrometry analysis, we
could map two of the four previously identified sites (K236 and
K245) in Fl(2)d (Supplementary Data 2), residing in the region
required for homodimerization and interaction with Vir (Fig. 2e,
Supplementary Fig. 4a). We noticed that Fl(2)d ubiquitination
was reduced in the Hakai KD condition; however, the overall
level of immunoprecipitated Fl(2)d was also diminished. We
therefore repeated this experiment in control condition and after
proteasome inhibition to prevent protein degradation. This
experiment confirmed our previous observations; Fl(2)d was
ubiquitinated and its protein intensity was strongly reduced upon
Hakai KD. However, upon proteasome inhibition, levels of Fl(2)d
as well as its ubiquitination remained unchanged despite efficient
Hakai depletion (Supplementary Fig. 8b). This indicates that
Hakai is not responsible for Fl(2)d ubiquitination, but is required
for its stability.
To get better insight into the function of Hakai as an E3
ubiquitin ligase and find other putative targets, we next
performed a ubiquitylome analysis in S2R+ cells in control
versus Hakai KD condition. Cells isotopically labelled with heavy
amino acids were depleted for Hakai and cells isotopically
labelled with light amino acids served as a control in the forward
experiment. A vice versa depletion was performed in the reverse
experiment (Supplementary Fig. 8c). Proteins were digested with
endo-proteinase Lys-C and peptides were further enriched with
di-glycine-lysine remnant-recognizing antibody to identify ubi-
quitination sites via LC-MS/MS. We found over 3000 ubiquitina-
tion sites, but unexpectedly not a single site was reproducibly
reduced in response to Hakai depletion and only one site in SesB
was 1.5-fold increased (Fig. 5a, Supplementary Data 3). There-
fore, this experiment suggests that Hakai does not act as an E3
ubiquitin ligase in Drosophila S2R+ cells. Alternatively, it is
possible that its ubiquitination activity depends on specific
external stimuli or that we have not quantified the ubiquitination
sites that are regulated by Hakai due to the limited depth of the
analysis.
We wondered what could explain the apparent discrepancy
between our in vivo results, indicating the importance of the
Hakai RING domain and the data obtained from S2R+ cells.
Previous crystal structure in mammals showed that the RING
domain is required for HAKAI dimerization40. One possibility
could be that the point mutations we generated in the RING
domain alter the ability of Hakai to dimerize and perhaps to
interact with other MACOM components. To test this idea, we
performed co-immunoprecipitation experiments by co-
transfecting S2R+ cells with Myc-GFP-tagged Hakai either wild
type or mutated in the RING domain and other components of
MACOM, including Hakai itself. While WT Myc-GFP-Hakai
strongly immunoprecipitated HA-Hakai, the RING mutant failed
to do so, indicating that, like in mammals, the RING domain is
required for Hakai homodimerization (Fig. 5b). More impor-
tantly, interactions with Fl(2)d and Vir were also strongly
compromised (Fig. 5c, d). We interpret this result as an indication
that Hakai dimerization is likely required for its association with
other MACOM components.
Hakai is required for stabilization of MACOM components.
Our results so far indicate that Hakai does not possess any ubi-
quitin activity towards MACOM components, and that it also
does not serve as a scaffold to permit the assembly of these
components. Nevertheless, as mentioned above, we found that
Hakai depletion strongly destabilized Fl(2)d protein levels. In
addition, we noticed in our co-immunoprecipitation experiments
that the level of protein input for Fl(2)d and Vir was consistently
reduced upon Hakai KD (Supplementary Fig. 5c, d), suggesting
that Hakai may be required to stabilize these subunits. For this
reason, we had to transfect twice the amount of these components
to have comparable input level and therefore interpretable co-
immunoprecipitation data. To confirm these observations, we
took an unbiased approach by performing a global proteome
analysis in S2R+ cells following Hakai depletion. As expected,
Hakai levels were strongly reduced, indicating a successful KD
(Fig. 6a). More strikingly, we identified seven additional proteins
that were strongly down regulated, and among them three
MACOM components: Fl(2)d, Flacc and Vir (Supplementary
Data 4). The extent of downregulation for Vir was similar as for
Hakai, indicating that Hakai loss has a particularly strong impact
on Vir stability. In contrast, we did not detect any substantial
changes in the protein levels of Nito, Mettl3 and Mettl14. We
could confirm by western blot the specific reduction of the Fl(2)d
level (Fig. 6b, c and Supplementary Fig. 9d). However, immu-
nofluorescence assay showed that its nuclear localization was not
affected (Supplementary Fig. 8d).
To examine whether the loss of Fl(2)d or Vir also impacts the
stability of other m6A writer components, we repeated the S2R+
proteome analysis after depletion of these proteins. We found
that Fl(2)d protein levels were significantly reduced upon vir KD
and vice versa (Supplementary Fig. 9a-c). Similarly, as shown
upon Hakai depletion, Flacc level was also decreased. However, in
both cases, levels of Hakai and Nito were not affected. This was
also confirmed by western blot (Fig. 6d and Supplementary
Fig. 9e). Collectively, these results indicate that Hakai functions in
stabilizing three MACOM components and this is likely the
reason why m6A levels are reduced upon its depletion.
The role of Hakai in MACOM component stabilization is
conserved in human. Given the high conservation of Hakai with
its human ortholog and its interaction with Vir, we wondered if
HAKAI function within MACOM is conserved in humans. To
this end, we depleted human HAKAI and VIRMA in HeLa and
U2OS cells and monitored the protein levels. We observed that
the loss of VIRMA had no effect on HAKAI level (Fig. 6e), as also
shown with the Drosophila homologues. In contrast, depletion of
HAKAI strongly reduced VIRMA levels but not the levels of
RBM15, the human ortholog of Nito. Altogether, these findings
indicate that the role of HAKAI within MACOM is conserved in
humans and that Hakai is indispensable for maintaining the
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functionality of m6A writer by ensuring the stability of MACOM
components (Fig. 7).
Discussion
We recently showed that two conserved sub-complexes, MAC
and MACOM interact to deposit m6A on mRNA in flies and
mice24. While the structure of the catalytic MAC, which consists
of the heterodimer METTL3 and METTL14, has been thoroughly
characterized28–30, our knowledge of MACOM is limited. In
particular, the full composition, assembly and exact function of
each subunit have remained unclear. Our study identifies Hakai
as an integral component of MACOM in Drosophila and human
cells. In line with this function, we show that Hakai interacts with
Vir and other MACOM components, and its depletion reduced
m6A levels and led to altered gene expression, resembling loss of
other MACOM subunits. Furthermore, flies lacking Hakai are
lethal and display aberrant splicing of Sex lethal, consistent with
the role of MACOM in sex determination and dosage
compensation pathways. The few individuals that escape lethality
are flightless, as shown earlier in other mutants of the m6A
pathway. Mechanistically, we found that Hakai is required to
stabilize several MACOM components, likely explaining its
requirement for m6A deposition.
The question that arises is whether all MACOM components
have now been identified. We and others have validated five
factors, which include Fl(2)d, Vir, Flacc, Nito and Hakai (this
study and14–16,24,33). Earlier biochemical studies estimated a
molecular weight of 875 kDa for the large form of the human
methyltransferase complex44. The calculated total molecular
weight of the combined five factors corresponds to 600 kDa,
which suggests that the complex contains additional factors or
multiple copies of the known factors. Our data show that Hakai,
Fl(2)d and Nito have the ability to self-interact (Supplementary
Fig. 4). If we assume that these three factors are present as dimers,
the total weight reaches up to 868 kDa, which would be consistent
with the predicted mass of MACOM. Nevertheless, additional
Fig. 5 Hakai RING domain is required for interaction with MACOM components. a Mass spectrometry analysis of Hakai-dependent ubiquitinated
proteins in S2R+ cells. Scatter plot of normalized forward versus inverted reverse experiments plotted on a log2 scale. The threshold was set to a twofold
enrichment or depletion (red dashed line). One protein in the top right quadrant is enriched in both replicates. Hakai depletion does not affect global
ubiquitination levels in D. melanogaster S2R+ cells. A complete list of quantified ubiquitylation sites after HAKAI depletion can be found in Supplementary
Data 3. b–d Co-immunoprecipitation experiments were carried out with lysates prepared from S2R+ cells transfected with Myc-GFP-tagged Hakai-long
(WT or RING mutant) and HA-tagged Hakai-long (b), HA-tagged Fl(2)d (c) and HA-tagged Virilizer fragment (d). In control lanes, S2R+ cells were
transfected with Myc-GFP alone and an identical HA-containing protein. Extracts were incubated with magnetic GFP binder beads and immunoblotted
using anti-Myc and anti-HA antibodies, as indicated. Two percent of input was loaded. The experiment was performed in the presence of RNase A. Images
shown are representative of two biological replicates. Source data for Western blots are provided as a Source Data file.
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biochemical and structural characterization will be required to
confirm the exact identity and stoichiometry of the different
complex components.
While Hakai is undoubtedly a core component of the complex,
it is surprising that its gene inactivation results in milder phe-
notypes in comparison to the inactivation of other MACOM
components. Indeed, the few females that escaped developmental
lethality in the Hakai loss-of-function mutant did not display
male sex combs and this phenotype was also not observed in a
sensitized background with reduced Hakai dosage. However, the
females did show male pigmentation on their abdomen, indi-
cating tissue-specific alteration of sex determination. These
milder defects are consistent with our quantification of the m6A
level in the Hakai mutant (Fig. 3), which appeared reduced but
not completely absent, as observed in the Mettl3 mutant14. Also,
Sxl splicing showed tissue-specific alterations, indicative of local
requirement for this factor. These results are consistent with a
previous study in Arabidopsis showing less pronounced impact of
Hakai on the m6A levels as well as on organismal development26.
This apparent discrepancy may be explained by the function we
uncovered in this work. Our data show that upon depletion of
Hakai the level of some of the other MACOM components is
reduced but not completely lost (Fig. 6), which suggest that the
remaining MACOM could still support methylation. In this case,
tissue-specific requirement may be mediated through differential
expression of factors that may impact on this residual interaction
and could determine tissue-specific levels of m6A. Additional
work would be required to test this hypothesis.
Fig. 6 Hakai regulates the stability of other MACOM components. a Mass spectrometry analysis of Hakai-dependent proteome in S2R+ cells. Scatter
plot of normalized forward versus inverted reverse experiments plotted on a log2 scale. The threshold was set to a 1.4-fold enrichment or depletion (red
dashed line). Proteins in the bottom left quadrant are decreased in both replicates. Heat map of proteins whose levels were reduced by >1.4-fold in both
replicates of the whole proteome analysis. Other components of the m6A writer complex and reader proteins are shown for comparison. A complete list of
quantified proteins can be found in Supplementary Data 4. b Levels of endogenous Fl(2)d, Mettl3 and Mettl14 proteins from control cells and cells depleted
for Hakai were analyzed by western blot. Tubulin was used as a loading control. Quantification of Fl(2)d, Mettl3 and Mettl14 levels from blots shown below
(left). The bar chart shows the mean with standard error (SE) of four biological replicates. ∗∗∗P= 2.48E−04 (Hakai KD). Unpaired two-tailed Student’s t-
test for equal variances. Hakai depletion strongly destabilizes Fl(2)d, but not Mettl3 or Mettl14 proteins. Relative expression levels of Hakai are shown as a
validation of its KD efficiency. The bar chart shows the mean with standard error (SE) of three technical measurements (Bottom right). c, d Analysis of Fl
(2)d levels upon Hakai, Mettl3, nito (c) or Hakai, vir, Flacc (d) depletion. Protein lysates from control and depleted cells were analyzed by western blot for
levels of endogenous Fl(2)d protein. Tubulin was used as a loading control. One representative experiment is shown and quantification of three biological
replicates is shown below. The bar chart shows the mean with standard error (SE). (c) ∗∗∗∗P= 4.74E−05 (Hakai KD), n.s.P= 0.80029 (Mettl3 KD) and
n.s.P= 0.05398 (Nito KD). (d) ∗∗P= 0.0057 (Hakai KD), P= 0.0012 (Vir KD) (Hakai KD), and n.s.P= 0.6061 (Flacc KD). Unpaired two-tailed Student’s t-
test for equal variances. e Western blots were carried out with lysates prepared from HeLa and U2OS cells transfected with scrambled siRNA or siRNA
against HAKAI or VIRMA. Extracts were immunoblotted using the indicated antibodies. Depletion of HAKAI reduced VIRMA levels while depletion of
VIRMA had no impact on HAKAI levels. Images shown are representative of two biological replicates. Source data for western blots, measurement of
protein levels and qPCR are provided as a Source Data file.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-23892-5
10 NATURE COMMUNICATIONS |         (2021) 12:3778 | https://doi.org/10.1038/s41467-021-23892-5 | www.nature.com/naturecommunications
In vertebrates, Hakai was shown to ubiquitinate E-cadherin
and promote its degradation35. In contrast, our data from Dro-
sophila cells provide no evidence for ubiquitination activity
towards MACOM components or any other proteins. Instead,
our work strongly suggest that Hakai is required for the stability
of three MACOM components, Vir, Fl(2)d and Flacc, indepen-
dently of its enzymatic activity. The question that remains is how
does Hakai exert this function. It was previously shown that the
so-called “orphan proteins” are unstable and get degraded if their
protein partners that constitute a common complex are absent.
Destabilization can be triggered due to aberrant protein folding,
altered localization or because of exposure of normally protected
protein binding interfaces45. It is therefore possible that Hakai
stabilizes other MACOM components via one of these mechan-
isms. If this model is true, other components of the complex are
also expected to stabilize each other. Indeed, we found that
protein levels of Vir, Fl(2)d and Flacc were also strongly reduced
upon loss of Vir or Fl(2)d (Fig. 6). Interestingly, in mES cells a
strong reduction of Wtap levels was previously reported upon loss
of Virma27 and a strong destablization of Zc3h13 was observed
upon depletion of Virma, Wtap or Hakai34, suggesting a con-
served mechanism for Hakai-Vir-Fl(2)d-Flacc stabilization
between flies and mice. We further demonstrated that protein
levels of Hakai and Nito are unperturbed upon depletion of other
MACOM components, suggesting that Hakai and Nito might
function in additional processes not linked to MACOM or m6A-
deposition. This is in agreement with observations that Hakai also
localizes in the cytoplasm, and with a study that found Nito
(RBM15) in an evolutionary conserved protein complex with
proteins unrelated to remaining MACOM components39.
Given our insights from the current study, we propose the
following model of MACOM assembly: (i) Fl(2)d-Vir-Hakai form
a minimal protein unit that is required for the assembly and
functionality of the remaining methyltransferase complex. (ii)
Stability of Fl(2)d and Vir depends on each other and Hakai, but
is largely independent of Flacc and Nito. (iii) Fl(2)d-Vir-Hakai
can interact with MAC, however, this is not sufficient for m6A
deposition. (iv) Joining of Flacc and Nito is essential for the
formation of a complete MACOM complex that can bind and
methylate its targets together with MAC.
In conclusion, our work revealed the requirement of Hakai for
m6A deposition in Drosophila. The apparent dependency of Fl(2)
d, Vir and Flacc for each other’s stability might be an important
mechanism that maintains an equilibrium of protein stoichio-
metry for a complete complex assembly in order to prevent
aberrant interactions of orphan subunits and unwanted m6A
installation. Given the critical role of m6A in multiple physiolo-
gical processes, it will be important to address whether pertur-
bation of this equilibrium, for instance, by single nucleotide
polymorphism, may impact the development or severity of
pathological conditions.
Methods
Drosophila stocks and genetics. Drosophila melanogaster CantonS was used as
the wild-type control. All Hakai alleles and corresponding chromosomal defi-
ciencies (Df(2L)Exel8041 and Df(2L)Exel6044) were re-balanced with a CyO bal-
ancer that is marked by actinGFP and w+ to determine the lethal stage and collect
homozygous Hakai null animals. Sexing at the larval stage was done by monitoring
the presence of the male gonad.
The P{VSH330548)attP40 Hakai RNAi line was obtained from Vienna
Drosophila Resource Center). Hakai was generated using the CRISPR-Cas9 system
following the previously described procedure46. Two independent guide RNAs
were designed using the gRNA design tool: www.crisprflydesign.org
(Supplementary Data 5). Oligonucleotides were annealed and cloned into pBFv-
U6.2 vector (National Institute of Genetics, Japan). The vector was injected into
embryos of TBX-0002 (y1, v1, P{nos-phiC31\int.NLS}X; attP40 (II)) flies by
Bestgene Inc. Flies were crossed with TBX-0008 (y2 cho2 v1/Yhs-hid; Sp/CyO) flies
to identify positive recombinant flies by eye colour marker (Vermillon). Males were
further crossed with CAS-0001 (y2, cho2, v1; attP40(nos-Cas9)/CyO) females.
Males carrying nos-Cas9 and U6-gRNA transgenes were screened for the expected
deletion using oligos in Supplementary Data 5.
For genetic interaction studies, we used Mettl3null and vir alleles as described24.
The da deficiency was Df(2L)BSC209.
Cloning. The plasmids used for immunohistochemistry and co-
immunoprecipitation assays (shown in Fig. 1d, e) were constructed by cloning the
corresponding cDNA in the pAC vector with the N-terminal Myc- tag (Hakai short



























m6A on mRNA m6A on mRNA
Fig. 7 Model showing the composition of the m6A methyltransferase complex in fly and human and the impact of Hakai on MACOM integrity. Top left
and right represent the human and fly m6A methyltransferase complexes, respectively. (Bottom) The depletion of Hakai leads to a reduction in protein
levels for Vir, Flacc and Fl(2)d.
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with the C-terminal HA tag, the corresponding cDNA was cloned in the Gateway-
based vector (pPWH) obtained from Drosophila Genomics Resource Center
(DGRC) at Indiana University as described in ref. 15. To generate the RING mutant
construct the corresponding mutations were introduced: histidine at position 183
was replaced by alanine in combination with cysteine to alanine conversion for the
residues 165, 168, 181, 186, 189, 198 and 201. The stability of the protein was not
affected by these mutations. Hakai long and Ring mutant cDNA were cloned in the
pUAST-eGFP-attB vector between BamH1 and Xba1 sites and the constructs were
sent to BestGene for injections.
Myc-GFP construct was generated by cloning Myc tag in directional cloning
within the Kpn1 restriction site in pAc5.1B-EGFP-V5-His vector. This construct
also has V5-His in frame after EGFP. This construct was used as negative control
for the experiment. Then all cDNAs were cloned in this vector for the subsequent
experiments. For HA-tagged constructs all the cDNAs were cloned in pAc5.1B-
lambdaN-HA vector in suitable restriction sites.
Cell culture, RNA interference and transfection. Drosophila S2R+ cells were
grown in Schneider’s medium (Gibco) supplemented with 10% FBS (Sigma) and
1% penicillin–streptomycin (Sigma). For RNA interference (RNAi) experiments,
PCR templates for the dsRNA were prepared using T7 megascript Kit (NEB).
dsRNA against bacterial β-galactosidase gene (lacZ) was used as a control for all
RNA interference (RNAi) experiments. S2R+ cells were seeded at the density of
106 cells/ml in serum-free medium and 7.5 μg of dsRNA was added to 106 cells.
After 6 h of cell starvation, serum supplemented medium was added to the cells.
dsRNA treatment was repeated after 48 and 96 h and cells were collected 24 h after
the last treatment. Effectene (Qiagen) was used to transfect vector constructs in all
overexpression experiments following the manufacturer’s protocol.
For knockdown in HeLa and U2OS cells, siRNAs against VIRMA (catalogue no.
s24832), HAKAI (catalogue no. s36537) as well as negative control siRNA were
purchased from Ambion. siRNAs were transfected with Lipofectamine 2000 RNAi
MAX (Invitrogen) according to the manufacturer’s protocol.
Drosophila cell lines. Drosophila S2R+ cells were embryonic-derived cells
obtained from the DGRC (at Indiana University; FlyBase accession FBtc0000150).
Drosophila BG3 cells were derived from larval nervous system and also obtained
from the DGRC(at Indiana University; FlyBase accession FBtc0000068). Both cell
lines were tested for Mycoplasma infection by RNA-seq experiments.
Drosophila staging. The staging experiment was performed as described
previously15 using D. melanogaster w1118 flies. A total of three independent
samples was collected for each Drosophila stage as well as for heads and ovaries.
Samples from the staging experiment were used for RNA extraction to analyze
m6A abundance in mRNA and expression levels of different transcripts during
Drosophila development.
RNA isolation and mRNA purification. Total RNA from S2R+ cells was isolated
using Trizol reagent (Invitrogen), and DNA was removed with DNase I treatment
(New England Biolabs). Fly heads from 3- to 5-day-old flies were separated and
homogenized in Trizol prior to RNA isolation. mRNA was isolated by two rounds
of purification with Dynabeads Oligo d(T)25 (New England Biolabs).
RT-PCR. cDNA was prepared using M-MLV reverse transcriptase (Promega).
Transcript levels were quantified using Power SYBR Green PCR master mix
(Invitrogen) and the oligonucleotides indicated in Supplementary Data 5.
For Sxl quantification, Total RNA was extracted using Tri-reagent (SIGMA)
and reverse transcription was done with Superscript II (Invitrogen) according to
the manufacturer’s instructions using an oligodT17V primer. PCR for Sxl was done
for 40 cycles with 1 μl of cDNA with primers Sxl F2
(ATGTACGGCAACAATAATCCGGGTAG) and Sxl R2
(CATTGTAACCACGACGCGACGATG). Experiments included three biological
replicates.
LC–MS/MS analysis of m6A levels. mRNA samples for LC-MS/MS analysis were
prepared as mentioned above. Three hundred nanograms of purified mRNA was
digested with 0.3 U Nuclease P1 from Penicillium citrinum (Sigma-Aldrich,
Steinheim, Germany) and 0.1 U Snake venom phosphodiesterase from Crotalus
adamanteus (Worthington, Lakewood, USA) in 25 mM ammonium acetate, pH 5,
supplemented with 20 µM zinc chloride for 2 h at 37 °C. Remaining phosphates
were removed by 1 U FastAP (Thermo Scientific, St Leon-Roth, Germany) in the
manufacturer-supplied buffer, in a 1 h incubation at 37 °C. The resulting nucleo-
side mix was then spiked with 13C stable isotope labelled nucleoside mix from
Saccharomyces cerevisiae RNA as an internal standard (SIL-IS) to a final con-
centration of 4 ng/µl for the sample RNA and 2 ng/µl for the SIL-IS. For the
analysis, 10 µl of the before mentioned mixture were injected into the LC–MS/MS
machine. Generation of technical triplicates was obligatory. All mRNA samples
were analyzed in biological triplicates. LC separation was performed on an Agilent
1200 series instrument, using 5 mM ammonium acetate buffer as solvent A and
acetonitrile as buffer B. Each run started with 100% buffer A, which was decreased
to 92% within 10 min Solvent A was further reduced to 60% within another 10 min
Until minute 23 of the run, solvent A was increased to 100% again and kept at
100% for 7 min to re-equilibrate the column (Synergi Fusion, 4 µM particle size, 80
Å pore size, 250 × 2.0 mm, Phenomenex, Aschaffenburg, Germany). The ultraviolet
signal at 254 nm was recorded via a DAD detector to monitor the main nucleo-
sides. MS/MS was then conducted on the coupled Agilent 6460 Triple Quadrupole
(QQQ) mass spectrometer equipped with an Agilent JetStream ESI source which
was set to the following parameters: gas temperature, 350 °C; gas flow, 8 l/min;
nebulizer pressure, 50 psi; sheath gas temperature, 350 °C; sheath gas flow, 12 l/
min; and capillary voltage, 3,000 V. To analyze the mass transitions of the unla-
belled m6A and all 13C m6A simultaneously, we used the dynamic multiple
reaction monitoring mode.
Analysis of m6A methylation by TLC. Total RNA was extracted with Trizol
(Invitrogen) and PolyA mRNA from oligo dT selection was prepared according to
the manufacturer (Promega). For each sample, 50 ng of polyA mRNA was cut with
RNAse T1 (1000U, Fermentas) and 5′-endlabeled using 10 U of T4 PNK (NEB)
and 0.5 µl [γ-32P] ATP (6000 Ci/mmol, 25 µM; Perkin-Elmer) in T4 PNK buffer for
2 h. The labelled RNA was precipitated, washed twice with 70% ethanol, resus-
pended in 10 µl of 50 mM sodium acetate buffer (pH 5.5) and digested with P1
nuclease (SIGMA) for 1 h at 37 °C. Two microliters of each sample was loaded on
cellulose F TLC plates (20 × 20 cm; Merck) and run in a solvent system of iso-
butyric acid:0.5 M NH4OH (5:3, v/v), as first dimension, and isopropanol:HCl:
water (70:15:15, v/v/v), as the second dimension. TLCs were repeated from bio-
logical replicates. The identity of the nucleotide spots was determined as
described14. For the quantification of spot intensities on TLCs, a storage phosphor
screen (K-Screen; Kodak) and Molecular Imager FX in combination with Quan-
tityOne software (BioRad) were used.
Immunostaining. For staining of Drosophila S2R+ and BG3 cells, cells were
transferred to the eight-well chambers (Ibidi) at a density of 2 × 105 cells per well.
After 30 min, cells were washed with 1× DPBS (Gibco), fixed with 4% for-
maldehyde for 10 min, and permeabilized with PBST (0.2% Triton X-100 in PBS)
for 15 min. Cells were incubated with mouse anti-Myc (1:2000, Enzo, 9E10) or
mouse anti-Flag (1:1000) in PBST supplemented with 10% donkey serum overnight
at 4 °C. Cells were washed three times for 15 min in PBST and then incubated with
secondary antibody and 1× DAPI solution in PBST supplemented with 10%
donkey serum for 2 h at 4 °C. After three 15-min washes in PBST, cells were
imaged with a Zeiss LSM 710 confocal microscope using a 63× oil immersion
objective.
For polytene chromosome staining, the long Hakai isoform was expressed in
salivary glands with C155-GAL4 as described14. Briefly, larvae were grown at 18 °C
under non-crowded conditions. Salivary glands were dissected in PBS containing
4% formaldehyde and 1% TritonX100, and fixed for 5 min, and then for another 2
min in 50% acetic acid containing 4% formaldehyde, before placing them in
lactoacetic acid (lactic acid:water:acetic acid, 1:2:3). Chromosomes were then
spread under a siliconized cover slip and the cover slip removed after freezing.
Chromosome were blocked in PBT containing 0.2% BSA and 5% goat serum and
sequentially incubated with primary antibodies (mouse anti-Pol II H5 IgM, 1:1000,
Abcam, and rat anti-HA MAb 3F10, 1:50, Roche) followed by incubation with
Alexa488- and/or Alexa647-coupled secondary antibodies (Molecular Probes)
including DAPI (1 µg/ml, Sigma).
Co-immunoprecipitation assay and western blot analysis of the Drosophila
MACOM subunits. For the co-immunoprecipitation assays shown in Fig. 1e, f,
different combinations of vectors with the indicated tags were co-transfected in
S2R+ cells. Forty-eight hours after transfection, cells were collected, washed with
DPBS, and pelleted by centrifugation at 400 × g for 10 min The cell pellet was lysed
in 1 ml of lysis buffer (50 mM Tris-HCl at pH 7.4, 150 mM NaCl, 0.05% NP-40)
supplemented with protease inhibitors and rotated head over tail for 15 min at 4 °
C. Nuclei were collected by centrifugation at 1000 × g for 10 min at 4 °C, resus-
pended in 300 μL of lysis buffer, and sonicated with five cycles of 30 s on and 30 s
off at the low power setting. Cytoplasmic and nuclear fractions were joined and
centrifuged at 18,000 × g for 10 min at 4 °C to remove the remaining cell debris.
Protein concentrations were determined using Bradford reagent (Bio-Rad). For
immunoprecipitation, 2 mg of proteins was incubated with 2 μg of anti-Myc
antibody coupled to protein A/G magnetic beads (Cell Signalling) in lysis buffer
and rotated head over tail overnight at 4 °C. The beads were washed three times for
15 min with lysis buffer, and immunoprecipitated proteins were eluted by incu-
bation in 1× NuPAGE LDS buffer (Thermo Fisher) for 10 min at 70 °C. Eluted
immunoprecipitated proteins were removed from the beads, and DTT was added
to 10% final volume. Immunoprecipitated proteins and input samples were ana-
lyzed by Western blot after incubation for an additional 5 min at 95 °C. For western
blot analysis, proteins were separated on a 8% SDS-PAGE gel and transferred to a
nitrocellulose membrane (Bio-Rad). After blocking with 5% milk in 0.05% Tween
in PBS for 1 h at room temperature, the membrane was incubated with primary
antibody in blocking solution overnight at 4 °C. Primary antibodies used were
mouse anti-Myc 1:2000 (#9E10, Enzo); mouse anti-HA 1:1000 (#16B12, COV-
ANCE); mouse anti-Tubulin 1:2000 (#903401, Biolegend); mouse anti-Fl(2)d 1:500
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(#9G2, DSHB), guinea pig anti-Mettl3 1:500 and rabbit anti-Mettl14 (Lence et al.
2016) 1:250 The membrane was washed three times in PBST for 15 min and
incubated for 1 h at room temperature with secondary antibody in blocking
solution. Protein bands were detected using SuperSignalWest Pico chemilumi-
nescent substrate (Thermo Scientific).
For the co-immunoprecipitation assays, shown in other figures, the following
modifications were made:Cells were harvested 72 h after transfection and washed
once with DPBS. The cell pellet was lysed in 0.5 ml of NET buffer (50 mM Tris-
HCl pH 7.5, 150 mM NaCl, 0.1% Triton and 1 mM EDTA pH 8.0 supplemented
with protease inhibitor and 10% glycerol) and sonicated for 3 cycles of 30 s at high
power setting followed by incubation with RNase A at ice for 30 min Lysate was
centrifuged at 15,000 × g for 10 min at 4 °C. Ten percent of the samples were taken
out as input samples and rest were incubated with GFP-magnetic beads on head to
toe rotary mixer at 4 °C. The beads were washed three times for 15 min with NET
buffer, and proteins were eluted by boiling the beads for 3 min at 95 °C in SDS-page
loading dye supplemented with 100 mM DTT. Where applicable, depletion of
indicated proteins was performed as described under “Cell culture, RNA
interference and transfection”. Double amounts of constructs were transfected in
several conditions, as indicated in corresponding figure legends.
Co-immunoprecipitation assay and western blot analysis of the human
MACOM subunits. For co-immunoprecipitation assay of the human MACOM
subunits, selected truncations of human MACOM components were cloned indi-
vidually into pcDNA3-derived vectors with His6-HA3-mCherry- or His6-FLAG3-
eGFP- tags. 0.25 mln. HEK293T cells were seeded into 2 ml media in 6-well plates,
grown for ~24 h (reaching ~75% confluency) and transfected with corresponding
plasmids, 1 µg each, using Xtreme® transfection agent (Roche) at 1:3 ratio. Cells
were washed with PBS and harvested ~48 h after transfection using 250 µl of the
lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM KCl, 1 mM EDTA, 0.1% Tween20),
supplemented with Roche protease inhibitor. The cells were then flash frozen in
liquid nitrogen and stored at −80 °C.
Upon thawing, the cells were further lysed by sonication for 30 s (0.5 s on/2 s
off) at 10% amplitude. 2 µg RNase A was added to rule out RNA-mediated
interactions. Soluble fraction was separated by centrifugation at full speed for 15
min and incubated with ~18 µl of magnetic anti-FLAG M2 beads (Sigma) for 1 h.
The beads were washed 3-4 times with the lysis buffer. The resultant beads were
mixed directly with the SDS loading dye and loaded onto 4-20% SDS gels (Biorad).
The gels were scanned for GFP and mCherry signals using Typhoon FLA 9500
filters of 473 nm and 532 nm, respectively.
Immunoprecipitation and ubiquitination analysis of MycGFP-Fl(2)d and
MycGFP-Nito. S2R+ cells were transfected with either MycGFP-tagged Nito or Fl
(2)d proteins as described above. Forty-eight hours post-transfection attached cells
in the 10-cm cell culture dish were washed 2x with cold PBS on ice. Cells were lysed
with 1 ml of modified RIPA lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl,
1 mM EDTA, 1% NP-40, 0,1% Na-deoxycholate), supplemented with complete
protease inhibitor cocktail, 5 mM beta-glycerophosphate, 5 mM NaF, 1 mM Na-
orthovanadate, 10 mM N-ethylmaleimide. Cells were then collected and incubated
for 10 min on ice and centrifuged 15 min at 16,000 × g at 4 °C. Supernatant was
transferred to a new tube and protein concentration measured using Bradford. 1.5
mg of proteins was incubated with 20 µL of washed GFPTrap-A beads (Chro-
motec) for 1 h at 4 °C end-over-end mixing. Beads were collected by centrifugation
(3000 rpm, 1 min) and the supernatant removed. Beads were washed 1× with
dilution buffer (10 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 1× Pro-
tease Inhibitor (Sigma), 10 mM N-ethylmaleimide), 3× with stringent wash buffer
(8 M Urea, 1% SDS in 1× PBS) and 1× with wash buffer (1% SDS in 1× PBS).
Forty-microlitres of 2× LDS sample buffer (Invitrogen) supplemented with 1 mM
DTT was added and beads were incubated for 10 min at 70 °C. Twenty-five percent
of eluted proteins were analyzed by WB. Primary antibodies used were as follows:
mouse anti-Myc 1:2000 (#9E10, Enzo) and mouse Ub antibody (P4D1,
Santa Cruz).
The remaining 75% of eluted proteins were used for ubiquitinome and
proteome analysis. Proteins were alkylated with 5.5 mM CAA for 30 min at RT in
the dark, stained using the Colloidal Blue Staining Kit (Life Technologies) and
digested in-gel using trypsin. Peptides were extracted from gel and desalted on
reversed-phase C18 StageTips47. Samples were then subjected to MS and peptide
identification.
Stable isotope labelling by amino acids in cell culture (SILAC). For SILAC
experiments (ubiquitinome and proteome of Hakai depleted cells), S2R+ cells were
grown in Schneider medium (Dundee Cell) supplemented with either heavy
(Arg10, Lys8) or light amino acids (Arg0, Lys0) (Sigma) for 6–8 passages and
successful incorporation was confirmed by LC–MS/MS.
Ubiquitylome and proteome analysis in S2R+ cells. Ubiquitylome and pro-
teome analysis of control and Hakai depleted SILAC S2R+ cells or Fl(2)d/Vir
depleted S2R+ cells was performed as described previously43,48. Following mod-
ifications were made: S2R+ cells were grown in Schneider medium (Dundee Cell)
supplemented with either heavy (Arg10, Lys8) or light amino acids (Arg0, Lys0)
(Sigma) or without supplement for the label-free proteomes (Fl(2)d and Vir KD).
Depletion of the different factors was performed with corresponding double-
stranded RNA three times during 6 days and scaled up to obtain 50 mg of proteins
per replicate (8–10, 15-cm cell culture dishes). Six hours prior to cell lysis, the
MG132 proteasome inhibitor was added to a final concentration of 15 μM. Cells
were lysed in modified RIPA lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl,
1 mM EDTA, 1% NP-40, 0.1% Na-deoxycholate) supplemented with complete
protease inhibitor cocktail (Roche), 5 mM -glycerophosphate, 5 mM NaF, 1 mM
Na-orthovanadate, 10 mM N-ethylmaleimide. 1.5 ml of buffer was used per each
15-cm dish. All lysates of the same transfection were combined in a falcon and
protein concentrations were measured by Bradford. Hundred micrograms of each
protein sample was collected for WB analysis. For ubiquitylome and proteome
analysis 25 mg of heavy and 25 mg of light labelled protein lysates were joined in a
1:1 ratio as follows: for forward experiment heavy labelled lysates with Hakai KD
and light labelled lysates with control KD were joined, and vice versa for reverse
experiment. 50 μg were then collected for proteome analysis. Finally, ice-cold
acetone was added to 80% final conc. (4xV) and precipitated O/N at −20 °C and
subjected to MS.
Label-free proteomes. A total of 15 × 106 S2R+ cells were transfected with Myc-
GFP-tagged HAKAI-long isoform in a 10-cm cell culture dish. In parallel, cells
were transfected with Myc-GFP as negative control. After 72 h, the cells were
harvested and washed with cold PBS. Cells were lysed with 1 ml of NET buffer (50
mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% Triton and 1 mM EDTA pH 8.0) and
supplemented with 10% Glycerol and Protease inhibitor cocktail (Roche). Lysates
were sonicated for 3 cycles of 30 s at a high power setting followed by incubation
with RNAse A on ice for 30 min Lysate was centrifuged at 15,000 × g for 10 min at
4 °C. The cleared lysates were incubated with GFP-magnetic beads on a head-to-toe
rotary mixer at 4 °C for 2 h. The beads were washed three times for 15 min with
NET buffer, and proteins were eluted by incubating at 70 °C in NuPAGE buffer.
Proteome and ubiquitylome analyses. MS sample preparation, proteome ana-
lysis, MS, and peptide identification were performed as described previously in
ref. 48. For peptide identification in SILAC samples, raw data files were analyzed
using MaxQuant (development version 1.5.2.8) to calculate the ratios between the
different conditions49. For the MaxQuant analysis, we used different parameter
groups to define group-specific parameters to invert the SILAC ratios in replicate 2
(Reverse). As result of these settings H/L in both experiments represents HAKAI
KD/Non-targeting control. The data with all quantified ubiquitylation sites (di-
glycine sites) and protein groups are provided as Supplementary_Data_3 (ubi-
quitylome analysis) and Supplementary_Data 4 (proteome analysis).
Analysis of label-free samples was performed using default setting for the LFQ
analysis in MaxQuant (1.5.2.8) and the Perseus software version 1.5.6.0 to perform
calculation of p value and Student’s t test50. Parent ion and MS2 spectra were
searched against a database containing D. melanogaster protein sequences obtained
from the UniProtKB released in May 2016 using Andromeda search engine51.
Yeast-two-hybrid assay (Y2H). Yeast-two-hybrid assay was performed using S.
cerevisiae yeast strain [trp1-901, leu2-3,112, ura3-52, his3-200, gal4Δ, gal80Δ,
LYS2::GAL1-HIS3, GAL2-ADE2, met2::GAL7-lacZ]. cDNAs of all tested genes
(Mettl3, Mettl14, Fl(2)d, Vir, Nito, Flacc, Hakai) were cloned in vectors pGAD424-
GW and pGBT9-GW, with Leu2 and Trp1 markers (kindly provided by Helle
Ulrich Lab, IMB Mainz) to express all candidates with either the C-terminal Gal4-
activation domain or the C-terminal Gal4-DNA binding domain, respectively.
Briefly, yeast cells were grown in YPD medium until they reached OD= 0.6. Cells
were centrifuged at 3500 rpm for 7 min at RT and washed 1× with water, 1× with
250 ml of SORB (100 mM LiOAc, 10 mM Tris pH 8.0, 1 mM EDTA pH 8.0, 1 M
Sorbitol) and 1× with 100 ml of SORB. Pellets were resuspended in 3.6 ml of SORB
and 400 ml of ssDNA carrier was added to competent cells. Fifty microlitres ali-
quots of cells were mixed with 100 ng of plasmid DNA. 6× volumes of PEG
solution (10 mM Tris pH 8.0, 1 mM EDTA pH 8.0, 40 (w/v)-% PEG 3350) were
then added to the cell-DNA mixture that was further incubated at RT for 30 min
Next, 1/9 of DMSO were added to cells that were subjected to 15 min heat shock at
42 °C. Following 2 min centrifugation at 1968 × g and RT, the cell pellet was
resuspended in 500 μL of water and 100 μL of cell solution was plated onto Trp-/
Leu- selection agar plates. After 3 days of incubation at 30 °C, 5 colonies of each
transformation were resuspended in 500 μL of water and 4 μL were spotted on
selection agar plates (Trp-/Leu- and Trp-/Leu-/His-). Plates were imaged in a 24-h
interval.
RNA-seq analysis. Raw data processing, differential expression analysis and
splicing analysis was done as described in ref. 24. All samples from GSE105900 as
well as the Hakai sample from GSE158663 were processed at the same time with
the same tools and tool versions. The controls used as a reference for the differ-
ential splicing and the differential expression analysis are the same. In short the
libraries were sequenced on a NextSeq500 with a read length of 85 bp single read
and converted to fastq using bcl2fastq (v.2.19) and mapped against Ensembl release
90 of D. melanogaster using STAR (52, v. 2.5.10)). Counts per gene were derived
using featureCounts (53, v. 2.5.1), Differential expression analysis was performed
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using Bioconductor/DESeq2 (54, v1.16.1)) and filtered for an FDR < 5%, default
independent filtering was used. Differential splicing analysis was performed using
rMATS (55, v. 3.2.5) and filtered for an FDR < 10%.
Statistics. For m6A level measurements datasets were compared using two-tailed
Student’s t test for unequal variances. Fl(2)d levels upon Control, Metll3, Nito, Vir,
Flacc and Hakai KD were compared using two-tailed Student’s t test for equal
variances. Normality was verified and homogeneity of variances was analyzed with
Levene’s test. Detailed descriptions of confidence intervals, effect sizes, degrees of
freedom are shown in the Source data. Statistical tests used for RNAseq data
analysis and mass spectrometry analysis are described in detail under relevant
sections of “Methods” part.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All data needed to evaluate the conclusions in the paper are present in the paper and/or
Supplementary Materials. Additional data related to this paper may be requested from
the authors. RNA-seq data are available in GEO: GSE158663. Proteomics data are
available in PRIDE: PXD022294. Source data are provided with this paper.
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